Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tenofovir Gel in Pregnancy
NCT01490671Phase 2Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Aug 2015
- Modality
- Implantable Devices, Transdermal Patches, Hydrogel Systems
01
Overview
A Phase 2 trial of tenofovir gel in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: withdrawn.
02
Drugs
tenofovir gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01490671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490671.